摘要
在六个月的开放性研究中发现对阿尔茨海默症患者静脉注射免疫球蛋白可以对其认知有益。其中一项研究表明这些含有少量抗体的制剂直接对抗单体和寡聚Aβ是其对患者治疗的有效基础。为了检验这一假设,我们将Gammagard®,静脉注射免疫球蛋白( IVIG)的一个版本,注入已存在淀粉样蛋白沉积物的淀粉样蛋白前体蛋白(APP)转基因小鼠侧脑室,对小鼠注射超过4周,并在最后两周的治疗进行行为学测试,对大脑进行组织病理学分析。我们发现人类免疫球蛋白G(h-IgG)染色广泛分布在小鼠前脑,包括大脑皮质和海马,有些皮层神经元出现了集中的h-IgG抗体,但是我们并没有检测到有h-IgG标记的淀粉样蛋白斑的证据。IVIG治疗的小鼠的表型相比注射生理盐水的小鼠在活动、学习和记忆,或淀粉样蛋白沉积无明显变化,但注射抗Aβ单克隆抗体的 APP小鼠的淀粉样蛋白沉积确实有所减少。这些数据并不支持 IVIG制剂中的抗Aβ抗体对认知起作用的观点。
关键词: 行为测试,CD45,刚果红,小胶质细胞活化,旋臂水迷宫,疫苗接种
Current Alzheimer Research
Title:Intraventricular Human Immunoglobulin Distributes Extensively but Fails to Modify Amyloid in a Mouse Model of Amyloid Deposition
Volume: 11 Issue: 7
Author(s): Aurelie Joly-Amado, Milene Brownlow, Jacob Pierce, Advaitaa Ravipati, Erin Showalter, Qingyou Li, Marcia N Gordon and Dave Morga
Affiliation:
关键词: 行为测试,CD45,刚果红,小胶质细胞活化,旋臂水迷宫,疫苗接种
摘要: Intravenous immunoglobulin infusions into Alzheimer patients have been found to provide cognitive benefit over a period of 6 mo in open label studies. One suggestion has been that these preparations contain small amounts of antibodies directed against monomeric and oligomeric Aβ which underlie their effectiveness in patients. To test this hypothesis, we infused Gammagard®, a version of intravenous immunoglobulin (IVIG), into the lateral ventricle of amyloid precursor protein (APP) transgenic mice with pre-existing amyloid deposits. Mice were infused over 4 weeks, and tested behaviorally for the last 2 weeks of treatment. Brains were analyzed for histopathology. We found widespread distribution of human–immunoglobulin G (h-IgG) staining in the mouse forebrain, including cerebral cortices and hippocampus. Some cortical neurons appeared to concentrate the h-IgG, but we did not detect evidence of amyloid plaque labeling by h-IgG. The IVIG-treated mice had no change in phenotype compared to saline-infused animals with respect to activity, learning and memory, or amyloid deposition. APP mice infused with an anti-Aβ monoclonal antibody did show some reduction in amyloid deposits. These data do not support the argument that anti-Aβ antibodies in IVIG preparations are responsible for cognitive benefits seen with these preparations.
Export Options
About this article
Cite this article as:
Aurelie Joly-Amado, Milene Brownlow, Jacob Pierce, Advaitaa Ravipati, Erin Showalter, Qingyou Li, Marcia N Gordon and Dave Morga , Intraventricular Human Immunoglobulin Distributes Extensively but Fails to Modify Amyloid in a Mouse Model of Amyloid Deposition, Current Alzheimer Research 2014; 11 (7) . https://dx.doi.org/10.2174/1567205011666140812114341
DOI https://dx.doi.org/10.2174/1567205011666140812114341 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Endocrine Regulation of Stem Cells: Physiological Importance and Pharmacological Potentials for Cell-Based Therapy
Current Stem Cell Research & Therapy Inhibition of Ceramide Metabolism Key Enzymes and its Implication in Cell Physiology and Pathology
Current Enzyme Inhibition Medial Temporal Lobe Volumes in Amnestic Mild Cognitive Impairment and Late-life Depression: Research Synthesis
Current Psychiatry Reviews CCR1 Antagonists: What Have We Learned From Clinical Trials
Current Topics in Medicinal Chemistry A Selective Review of the Research on Juvenile Bipolar Disorder: Implications for Struggling Clinicians
Adolescent Psychiatry Chronic Methylphenidate-Effects Over Circadian Cycle of Young and Adult Rats Submitted to Open-Field and Object Recognition Tests
Current Neurovascular Research The Role of Orexin System in Antipsychotics Induced Weight Gain
Current Psychiatry Reviews Stress, Depression, Resilience and Ageing: A Role for the LPA-LPA1 Pathway
Current Neuropharmacology Medicinal Plants: A Natural Chaperones Source for Treating Neurological Disorders
Protein & Peptide Letters Mechanisms Underlying the Hepatotoxic Effects of Ecstasy
Current Pharmaceutical Biotechnology Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
Current Cancer Drug Targets Blood-brain Barrier Disruption May Contribute to White Matter Lesions in the Setting of Internal Jugular Venous Stenosis
Current Neurovascular Research Serotonin 5-HT2A and 5-HT2C Receptors as Potential Targets for Modulation of Psychostimulant Use and Dependence
Current Topics in Medicinal Chemistry PET Radiopharmaceuticals for Personalized Medicine
Current Drug Targets Tricyclic Antidepressants-loaded Biodegradable PLGA Nanoparticles: In Vitro Characterization and In Vivo Analgesic and Anti-Allodynic Effect
Current Nanoscience Cognitive Behavioral Therapy in Prodromal Psychosis
Current Pharmaceutical Design The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
Current Neuropharmacology Computational Advances in Chronic Diseases Diagnostics and Therapy - II
Current Drug Targets The Effect of Pharmacotherapy for Attention Deficit Hyperactivity Disorder on Risk of Seizures in Pediatric Patients as Assessed in an Insurance Claims Database
Current Drug Safety Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective
Current Neurovascular Research